[Study by the Professional Organization of German Transfusion Physicians on epidemiology of HIV- and hepatitis infections in blood donors] NLM AIDSLINE Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Study by the Professional Organization of German Transfusion Physicians on epidemiology of HIV- and hepatitis infections in blood donors]

Beitr Infusionsther Transfusionsmed. 1997;34:1-4. Unique Identifier : AIDSLINE MED/98019468
Gluck D; Maurer C; Kubanek B; Studiensekretariat des Berufsverbands Deutscher Transfusionsmediziner; e. V., Ulm, Deutschland.

Abstract: The frequency of the seromarkers of HIV, HCV, and HBV in the donor population from all donor centers in Germany became available from the multicenter study of the transfusion services. From these data the risk of virus transmission by blood products can be estimated at 1:1 million for HIV and 1:50,000 for HBV. For HCV, preliminary data indicate the risk for Germany in less than 1:20,000. The risk is even lower, with less than 1:200,000 when calculated from seroconversion data of a rural donor population. The safety of blood products has been very much improved due to the continuous donor selection over the last years and by the epidemiologic situation in Germany.
Keywords: *Blood Donors/STATISTICS & NUMER DATA *Hepatitis B/EPIDEMIOLOGY *Hepatitis C/EPIDEMIOLOGY *HIV Seropositivity/EPIDEMIOLOGYKWDblooddonors/statistics&numerdataKWDhepatitisb/epidemiologyKWDhepatitisc/epidemiologyKWDhivseropositivity/epidemiology
980330
M9831221

Copyright © 1998 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .